Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy.

Date publication

mai 2020

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HOEFFEL Christine , Pr LABROUSSE Marc

Tous les auteurs :
Brenet E, Barbe C, Hoeffel C, Dubernard X, Merol JC, Fath L, Servagi-Vernat S, Labrousse M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32422975

Résumé

To investigate the predictive capacity of early post-treatment diffusion-weighted magnetic resonance imaging (MRI) for recurrence or tumor progression in patients with no tumor residue after chemo-radiotherapy (CRT) for head and neck squamous cell carcinoma, and, to assess the predictive capacity of pre-treatment diffusion-weighted MRI for persistent tumor residue post-CRT.

Mots clés

chemo-radiotherapy, diffusion-weighted magnetic resonance imaging (MRI), head and neck neoplasm, recurrence

Référence

Cancers (Basel). 2020 May 14;12(5):